Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Protagenic Therapeutics Inc’s current trading price is -84.59% away from its 52-week high, while its distance from the 52-week low is 20.04%. The stock’s price range over this period has fluctuated between $0.24 and $1.87. The company, operating within the financial sector, had a trading volume of approximately 0.91 million for the day, which was noticeably higher than the average daily share volume of 0.38 million over the last 3 months.
The market performance of Protagenic Therapeutics Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $1.87 on 05/22/24, while the lowest value for the same duration was $0.24 on 02/25/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Protagenic Therapeutics Inc (PTIX) has experienced a quarterly decline of -55.68% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.09M and boasts a workforce of 3 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.5114, with a change in price of -0.3414. Similarly, Protagenic Therapeutics Inc recorded 317,178 in trading volume during the last 100 days, posting a change of -54.23%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for PTIX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
PTIX Stock Stochastic Average
Today’s raw stochastic average for Protagenic Therapeutics Inc over the last 50 days is 8.59%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 24.17%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 11.80% and 6.82%, respectively.
PTIX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded a decrease of -41.20%. However, over the last six months, the performance has been stronger by -55.65%. The price of PTIX decreased -38.32% over the last 30 days. And in the last five days, it has surged by 10.81%.
